Enterprise Value
N/A
4 min ago
Summary
- PACB enterprise value is not available.
Performance
PACB Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
PACB Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | - | +4.5% | +4.5% |
| 1 m1 month | - | +3.8% | +3.8% |
| 3 m3 months | - | -41.3% | -41.3% |
| 6 m6 months | - | -12.7% | -19.2% |
| ytdytd | - | -23.6% | -23.6% |
| 1 y1 year | - | -65.8% | -68.8% |
| 5 y5 years | - | -28.0% | -62.5% |
PACB Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | ||||
| 3 m | 3-month | $1.54 B | $1.38 B | ||
| 6 m | 6-month | $1.54 B | $1.28 B | ||
| 1 y | 1-year | $2.10 B | $1.16 B | ||
| 3 y | 3-year | $4.22 B | $1.16 B | ||
| 5 y | 5-year | $9.84 B | $384 M | ||
| alltime | all time | $9.84 B | $32 M |
Pacific Biosciences Of California Enterprise Value History
| Date | Value |
|---|---|
| 2022 | $2.48 B(-50.6%) |
| 2021 | $5.02 B(+1.4%) |
| 2020 | $4.95 B(+504.2%) |
| 2019 | $819.08 M(-26.1%) |
| 2018 | $1.11 B(+264.2%) |
| 2017 | $304.10 M(-13.5%) |
| Date | Value |
|---|---|
| 2016 | $351.51 M(-65.9%) |
| 2015 | $1.03 B(+85.1%) |
| 2014 | $557.13 M(+67.0%) |
| 2013 | $333.60 M(+544.8%) |
| 2012 | $51.73 M(-47.2%) |
| 2011 | $97.96 M(-85.9%) |
| 2010 | $696.31 M |
FAQ
- What is the all time high enterprise value for Pacific Biosciences of California?
What is the all time high enterprise value for Pacific Biosciences of California?
Pacific Biosciences of California all-time high enterprise value is $9.84 B